This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
| Thursday’s UK 100 Leaders | Price (p) | % Chg |
| PEARSON PLC | 605.0 | 7.8% |
| AVIVA PLC | 297.5 | 4.6% |
| ITV PLC | 63.3 | 3.9% |
| MONDI PLC | 1,469.5 | 3.1% |
| GVC HOLDINGS PLC | 724.0 | 2.9% |
| Thursday’s UK 100 Laggards | Price (p) | % Chg |
| GLENCORE PLC | 180.3 | -8.1% |
| LAND SECURITIES GROUP PLC | 579.8 | -5.0% |
| TAYLOR WIMPEY PLC | 118.4 | -4.3% |
| INTL CONSOLIDATED AIRLINE-DI | 186.1 | -4.0% |
| BARRATT DEVELOPMENTS PLC | 500.0 | -3.9% |
| Major World Indices | Price | % Chg | 1 Year |
| UK 100 INDEX | 6,027 | -1.3% | -16.0% |
| DOW JONES INDUS. AVG | 27,387 | 0.7% | 5.2% |
| DAX INDEX | 12,592 | -0.5% | 8.9% |
| NIKKEI 225 | 22,418 | -0.4% | 9.3% |
| S&P/ASX 200 INDEX | 6,042 | 0.7% | -7.3% |
| Commodities | Units | Price | % Chg |
| WTI Crude Oil (Nymex) | USD/bbl. | 41.95 | -0.57% |
| Brent Crude (ICE) | USD/bbl. | 45.13 | -0.09% |
| Gold Spot | USD/t oz. | 2,064 | 0.0% |
| Copper (Comex) | USd/lb. | 291 | -0.2% |
Click graph to enlarge
UK 100 called to open flat this morning at 6025. Calls for a muted open come as Trump orders bans on China-owned TikTok and WeChat. During trading in the US yesterday, The Dow Jones closed up 185 points, or 0.7%. The S&P 500 rose 0.6%, while the Nasdaq added 1% to close above 11,000 points for the first time. This followed the latest figures from the U.S. Department of Labour, which showed that 1.186 million people filed initial claims for unemployment benefits in the week ended Aug. 1, compared with the 1.4 million economists expected. In commodity news Gold extended a record rally to a fifth straight day.
AstraZeneca: Japan will soon agree a supply deal for over 100 million doses of AstraZeneca’s coronavirus vaccine, while Brazil will provide $365m in funds to purchase and produce the shot.
Hargreaves Lansdown reports FY pretax profit jumps 24% to £378.3m with net new business of £7.7bn. Their total dividend is up 31% to 54.9p per share. They recorded 1,412,000 active clients, an increase of 188,000 from 2019.
Hikma Pharmaceuticals raises annual sales outlook for top two units and reported higher H1 2020 profit as hospitals and distributors stocked up on critical medicines during COVID-19 pandemic. Core operating profit rose 15% Y-o-Y to $284m.
Rightmove reported a lower H1 2020 operating profit as the coronavirus outbreak halted property deals, hammering agents and developers who are its main clients. Average revenue per advertiser fell 34% to £712 per month, whereas operating profit slid to £61.7m (2019: £108.2m).
Rolls Royce‘s activist shareholder ValueAct Capital has sold its entire stake in the company.
Standard Life Aberdeen reports that pre-tax profit fell 30% to £195m in H1 2020 due to the impact of the coronavirus pandemic on markets. Fee-based revenue dropped 13% to 706m due to 2019 outflows, clients switching to lower-fee assets in the tough environment and a scheduled mandate withdrawal by Lloyds Banking Group. Assets under management fell 6% and the interim dividend is unchanged at 7.3p (above analysts forecast of 6.8p).
Hargreaves Lansdown
Hikma Pharmaceuticals
Rightmove
Standard Life Aberdeen
Metrobank
Acacia Mining PLC
Chinese Trade Balance
German Retail Sales
US Nonfarm Payrolls
UK 100:
Phoenix Group Holdings
Smurfit Kappa Group
Legal & General Group
Aviva
Diageo
BP
Ashtead Group
GlaxoSmithKline
Pearson
Royal Dutch Shell B
Royal Dutch Shell A
AstraZeneca
SEGRO
UK 250:
Direct Line Insurance Group
Ferrexpo
Centamin
Renewables Infrastructure Group
Greencoat UK Wind
Civitas Social Housing
GCP Student Living
Tritax Big Box REIT
Scottish American Investment Company
UK Commercial Property REIT
ICG Enterprise Trust
Spirent Communications
Lancashire Holdings
BMO Commercial Property Trust
Games Workshop Group
For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.